Melatonin

Studies of melatonin in people

91 studies gave melatonin to people and measured what changed

What changedDesignPeopleSource

down: Decreases ghrelin4.35 ± 0.90 pg/mL vs. 4.78 ± 0.75 pg/mL; p = 0.013

no change: Has no effect on 2-arachidonoylglycerol

no change: Has no effect on hedonic appetite intensity

Randomized trial8 weeks41 peopleWomen35.68 ± 7.51 yearsOverweight or obesity and high hedonic appetiteScientific reports, Oct 18, 2026

down: Decreases low-density lipoprotein cholesterol

down: Decreases triglyceride

Randomized trial12 weeks38 peopleWomenPostmenopausal womenExperimental gerontology, Oct 10, 2026

up: Increases bone mineral density

up: Improves quality of life

Randomized trial6 months60 peopleWomen≥45 yearsMidlife adults; Older adults; Postmenopausal women; with calcium and vitamin D supplementationInternational Journal of Drug Delivery Technology, Jun 29, 2026

up: Improves leg muscle strength

up: Improves unipedal static balance

Randomized trial12 weeks36 peoplePost-interventionInternational journal of food sciences and nutrition, Jun 24, 2026

down: Decreases sleep disturbances-3.6 ± 1.6 vs. -1.4 ± 0.5

Randomized trialeight weeks200 peopleBothaged 18 to 50 yearsAdults aged 18 to 50 years who met the DSM-5 diagnostic criteria for sleep disturbanceClocks & sleep, Mar 27, 2026

down: Decreases protein carbonyls

up: Increases ferric reducing ability of plasma

Randomized trialthree months51 peopleWomenIn PCOS patients receiving metforminJournal of gynecology obstetrics and human reproduction, Mar 23, 2026

down: Decreases climacteric symptoms−15.8% vs +33.5%

up: Improves sleep quality

no change: Has no effect on total sleep duration

Randomized trial3 months46 peoplewomenmean age 47.2 ± 5.4 years, range 39–60 yearsWomen in the climacteric who worked fixed-shiftsJournal of pineal research, Mar 1, 2026

up: Improves sleep efficiency

up: Improves subjective psychological well-being

Randomized trial28 days59 people30–60 yearsMidlife adults; healthy adults with poor sleep qualityPreprints.org, Feb 11, 2026

no change: Has no effect on delirium3.64% vs 1.85%, p=1.000

no change: Has no effect on sleep durationp=0.136

no change: Has no effect on mortality3.64% vs 1.85%, p=1.000

Randomized trialup to 5 days109 people≥65 yearsOlder adults; medically hospitalised older patientsBMJ open, Jan 27, 2026

up: Improves sleep quality

TrialHospitalized patients; before-and-after comparisonCureus, Dec 31, 2025

no change: Has no effect on sleep quality

no change: Has no effect on sleep efficiency

Randomized trial30 days64 people40 to 80 yearsMidlife adults; Older adults; advanced primary open-angle glaucomaOphthalmology. Glaucoma, Dec 11, 2025

down: Decreases hot flashes

up: Improves quality of life

up: Improves sexual function

Randomized trialfour weeks60 peopleAdultBreast cancer patients receiving antihormone medicationsAdvanced biomedical research, Oct 31, 2025

no change: Has no effect on anthropometry

no change: Has no effect on physical function

no change: Has no effect on health-related quality of life

Randomized trial10 weeks10 peopleWomen60–75 yearsOlder adults; Postmenopausal women; Breast cancer survivors receiving an adapted physical activity programFrontiers in sports and active living, Jun 23, 2025

up: Improves best-corrected visual acuity

down: Decreases choroidal vascularity index

Trialone month14 peoplePatients with CSCRCureus, Dec 29, 2024

no change: Has no effect on postoperative neurocognitive disorder

Randomized trialthe night before surgery and the first three postoperative nights176 peoplemales≥ 60 yearsPatients aged ≥ 60 undergoing elective TURP under spinal anesthesiaClinics (Sao Paulo, Brazil), Dec 26, 2024

down: Decreases oxidative stress markers

up: Improves mitochondrial function

Treated cohort≥ 8 weeks161 peopleWomen35–45 yearsMidlife adultsReproductive biology and endocrinology : RB&E, Nov 8, 2024

no change: Has no effect on cognitive function

Randomized trial12 weeks40 peopleBoth68.2 [4.7] yearsOlder adults; Mild Cognitive ImpairmentJournal of pineal research, Nov 1, 2024

up: Improves sleep onset latency7:04 min faster compared with placebo

up: Increases total sleep timeabout 30 min

up: Increases cortisol

Randomized trial2 days (crossover design)64 peopleaverage age was 41.11 years oldHealthy volunteers aged at least 18 yearsPharmacology research & perspectives, Jun 1, 2024

no change: Has no effect on sleep disturbance

down: Decreases sleep disturbance

down: Decreases pain0.24, 95% CI 0.08–0.39

Randomized trial6 weeks58 peopleBothPatients with severe chronic pain for at least 3 monthsBritish journal of anaesthesia, Feb 14, 2024

no change: Has no effect on type 2 diabetes

no change: Has no effect on fat intake

Randomized trial12 weeks27 peopleWomenPatient cohortsFrontiers in nutrition, Jan 22, 2024

no change: Has no effect on insulin resistance

no change: Has no effect on diurnal blood pressure

up: Improves sleep qualityp < 0.001

Randomized trial12 weeks24 peoplePharmacological research, Nov 27, 2023

up: Improves exercise capacity71 ± 26 vs. 25 ± 36 m, p < 0.01

up: Improves health status-11 ± 6 vs. -3 ± 5, p < 0.01

up: Improves quality of life-6.9 ± 3.0 vs. -1.9 ± 2.4, p < 0.01

Randomized trial12 weeks39 peopleDuring pulmonary rehabilitation in patients with COPDRespiratory medicine, Nov 7, 2023

down: Decreases nighttime systolic blood pressure100 ± 10 vs 105 ± 10 mmHg, P = 0.01

no change: Has no effect on 24-h mean arterial pressure82 ± 5 vs 83 ± 6 mmHg, P = 0.23

no change: Has no effect on blood pressure reactivityall P > 0.05

Randomized trial10 days22 peopleBoth26.5 ± 3.1 yrGeneral population; on a high-sodium dietAmerican journal of physiology. Regulatory, integrative and comparative physiology, Aug 29, 2023

up: Improves postural balance

up: Improves quality of life

Randomized trial12 weeks33 peopleIn hemodialysis patientsTherapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, Feb 9, 2023

no change: Has no effect on sleep qualityPSQI 5.6 vs 6.1, P = 0.615

no change: Has no effect on pain

no change: Has no effect on quality of life

Randomized trial4 weeks84 peoplemean age 41.8 ± 15.5 years and 41.3 ± 14.0 yearsPostoperative orthopedic trauma patientsInjury, Oct 14, 2022

down: Decreases insulin sensitivitydifference −0.6 [−1.13 to −0.13] mg/(kg × min)

Randomized trialtwo 12‐week treatment periods17 peoplemale sexage 40–70 yearsCaucasian men aged 40–70 years with type 2 diabetesJournal of pineal research, Jun 9, 2022

up: Improves sleep efficiency

up: Increases stage 2 non-rapid eye movement sleep duration

Randomized trial24 calendar days24 people13 women, 11 menmean ± SD: 64.2 ± 6.3 yearsMedically and psychologically healthy older adultsJournal of pineal research, Apr 19, 2022

no change: Has no effect on carotid intima-media thicknessP = 0.51, P = 0.16, P = 0.76, P = 0.15

no change: Has no effect on pulse wave velocityP = 0.55

no change: Has no effect on C-reactive proteinP = 0.81

Randomized trial24 weeks32 peopleDiabetic nephropathyClinical nutrition ESPEN, Jan 6, 2022

down: Decreases sleep disordersP ≤0.001

down: Decreases depressionP ≤0.001

down: Decreases anxietyP = 0.001

Randomized trial3 months60 peoplePatient cohortsSaudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, Jan 1, 2022

up: Increases ventilator-free days16.90 ± 9.24 days in the melatonin group vs. 10.00 ± 10.94 days in the placebo group

down: Decreases vasopressor requirement6.21 ± 5.12 reduction vs 3.20 ± 3.95 reduction

up: Increases vasopressor-free days12.75 ± 7.43 days vs. 10.15 ± 6.12 days

Randomized trialfive consecutive nights40 people67.5% of the patients were men54.9 ± 12.21 yearsAdult patients with early septic shockIrish journal of medical science, Sep 1, 2021

down: Decreases body weight

down: Decreases body fat mass percentage

Randomized trial12 weeks44 peopleBothPatient cohortsBioMed research international, Aug 10, 2021

down: Decreases body weight

Randomized trial12 weeks27 peopleWomen37.1 yo, ±5.9 yoIn early chronotypesJournal of pineal research, Jun 20, 2021

down: Decreases pittsburgh Sleep Quality Index score

up: Increases HDL-C2.76 mg/dl [95% CI 0.57, 4.95]

Randomized trial8 weeks84 peopleWomen18-40 yearsWomen with PCOS, compared with baselineNutrition & metabolism, Jun 6, 2021

down: Decreases TNF-alphaP < 0.05

Randomized trial8 weeks84 peopleWomen18-40 years oldIn women with polycystic ovary syndromeBiological trace element research, May 19, 2021

down: Decreases poor-quality embryos0.27 vs. 0.80, P = 0.028

no change: Has no effect on clinical pregnancy rate14% vs. 7%, P = 0.302

Trial90 peopleBothInfertile couples undergoing IVFNaunyn-Schmiedeberg's archives of pharmacology, Mar 8, 2021

down: Decreases malondialdehydeP<0.001

down: Decreases LDL cholesterolP=0.007

no change: Has no effect on rheumatoid arthritisP>0.05

Randomized trial12 weeks64 peoplePatient cohortsClinical rheumatology, Mar 5, 2021

no change: Has no effect on cardio-ankle vascular index

no change: Has no effect on mitochondrial DNA copy number

no change: Has no effect on HOMA-IR

Randomized trialsix weeks38 peopleAll subjects were women55 years and olderWomen over 55 years old with insomniaInternational journal of environmental research and public health, Mar 4, 2021

down: Decreases fasting blood glucoseβ = -10.64 mg/dL; 95% CI: -20.37 to -0.90; P < .05

up: Increases HDL cholesterolβ = 2.75 mg/dL, 95% CI: 0.75 to 4.75; P < .05

up: Increases total antioxidant capacityβ = 140.45 mmol/L; 95% CI: 80.48 to 200.41; P < .001

Randomized trial12 weeks60 peopleIn patients with diabetic nephropathyIranian journal of kidney diseases, Jan 1, 2021

up: Improves sleep quality69.7 vs 60.7, p = 0.029

down: Lowers the risk of poor sleepRR 0.21, 95% CI 0.06-0.71

no change: Has no effect on delirium

Randomized trialup to seven consecutive nights203 peopleadultCritically ill ICU patientsCritical care medicine, Dec 1, 2020

down: Decreases disease severityβ -2.33, 95% CI -3.57 to -1.09

down: Decreases C-reactive proteinβ -0.94 mg/L, 95% CI -1.55 to -0.32

up: Increases total antioxidant capacityβ 108.09 mmol/L, 95% CI 78.21 to 137.97

Randomized trial12 weeks60 peopleIn patients with Parkinson's diseaseClinical neurology and neurosurgery, May 1, 2020